The reduction in brain volume observed in AD patients is mainly due to hippocampal degeneration, and the main pathological hallmarks of AD include amyloid-beta (Aβ) deposits that form plaques in the extracellular space and neurofibrillary tangles formed by hyperphosphorylated Tau protein (pTau). Here, MAPT is linked to Alzheimer disease.